Evidence map›Paper›PMID 29062841›Full record

ArticleJournal of immunology research2017

Propyl Gallate Exerts an Antimigration Effect on Temozolomide-Treated Malignant Glioma Cells through Inhibition of ROS and the NF-

Jen-Tsung Yang, I-Neng Lee, Fung-Jou Lu, Chiu-Yen Chung, Ming-Hsueh Lee, Yu-Ching Cheng, Kuo-Tai Chen, Ching-Hsein Chen

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Development and Characterization ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jen-Tsung YangDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
I-Neng LeeDepartment of Medical Research, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Fung-Jou LuInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan.ORCID 0000-0003-3765-7535
Chiu-Yen ChungDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Ming-Hsueh LeeDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Yu-Ching ChengDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Kuo-Tai ChenDepartment of Neurosurgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Ching-Hsein ChenDepartment of Microbiology, Immunology and Biopharmaceuticals, College of Life Sciences, National Chiayi University, Chiayi City 60004, Taiwan.ORCID 0000-0003-0578-7116
Chiayi Chang Gung Memorial Hospital · TWChang Gung University · TWChung Shan Medical University · TWNational Chiayi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we demonstrated that temozolomide (TMZ) and propyl gallate (PG) combination enhanced the inhibition of migration in human U87MG glioma cells. PG inhibited the TMZ-induced reactive oxygen species (ROS) generation. The mitochondrial complex III and NADPH oxidase are two critical sites that can be considered to regulate antimigration in TMZ-treated U87MG cells. PG can enhance the antimigration effect of TMZ through suppression of metalloproteinase-2 and metalloproteinase-9 activities, ROS generation, and the NF-

Indexed as

ApoptosisCell Line, TumorCell MovementDacarbazineDrug SynergismDrug Therapy, CombinationGliomaHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9NF-kappa BPropyl GallateReactive Oxygen SpeciesSignal TransductionTemozolomideDacarbazineMatrix Metalloproteinase 2Matrix Metalloproteinase 9NF-kappa BPropyl GallateReactive Oxygen SpeciesTemozolomide

Identifiers

PMID29062841
PMCPMC5618759
OpenAlexW2755613368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.